Author

Agata N Burska

Postdoctoral Research Fellow; Nazarbayev University - Cited by 1,612 - mitochondria - cancer - autoimmune diseases - diabetes - atherosclerosis

Biography

Dr. Agata N Burska, Currently working in the The Leeds Trust Teaching Hospital, studied in The University of Leeds & NIHR Leeds Musculoskeletal Biomedical Research Unit, Leeds, UK, Research interests are Autoimmune Diseases, Diabetes, Atherosclerosis, Adipocytokines  
Title
Cited by
Year
The analysis of in vivo aging in human bone marrow mesenchymal stromal cells using colony-forming unit-fibroblast assay and the CD45lowCD271+ phenotype
P Ganguly, JJ El-Jawhari, AN Burska, F Ponchel, PV Giannoudis, ...Stem cells international 2019, 2019201
59
2019
Synovial tissue heterogeneity in rheumatoid arthritis and changes with biologic and targeted synthetic therapies to inform stratified therapy
L Ouboussad, AN Burska, A Melville, MH BuchFrontiers in medicine 6, 45, 2019201
50
2019
Incidental significant arrhythmia in scleroderma associates with cardiac magnetic resonance measure of fibrosis and hs-TnI and NT-proBNP
LA Bissell, RB Dumitru, B Erhayiem, G Abignano, G Fent, A Kidambi, ...Rheumatology 58 (7), 1221-1226, 2019201
33
2019
Defining remission in rheumatoid arthritis: does it matter to the patient? A comparison of multi-dimensional remission criteria and patient reported outcomes
HL Gul, G Eugenio, T Rabin, A Burska, R Parmar, J Wu, F Ponchel, ...Rheumatology 59 (3), 613-621, 2020202
30
2020
T-cell subset abnormalities predict progression along the Inflammatory Arthritis disease continuum: implications for management
F Ponchel, AN Burska, L Hunt, H Gul, T Rabin, R Parmar, MH Buch, ...Scientific Reports 10 (1), 3669, 2020202
21
2020
Dynamics of early signalling events during fracture healing and potential serum biomarkers of fracture non-union in humans
AN Burska, PV Giannoudis, BH Tan, D Ilas, E Jones, F PonchelJournal of clinical medicine 9 (2), 492, 2020202
19
2020
Gene expression and functional comparison between multipotential stromal cells from lateral and medial condyles of knee osteoarthritis patients
C Sanjurjo-Rodriguez, TG Baboolal, AN Burska, F Ponchel, JJ El-Jawhari, ...Scientific Reports 9 (1), 9321, 2019201
16
2019
Predictors of subclinical systemic sclerosis primary heart involvement characterised by microvasculopathy and myocardial fibrosis
RB Dumitru, LA Bissell, B Erhayiem, G Fent, A Kidambi, P Swoboda, ...Rheumatology 60 (6), 2934-2945, 2021202
16
2021
Quantifying circulating Th17 cells by qPCR: potential as diagnostic biomarker for rheumatoid arthritis
AN Burska, A Thu, R Parmar, I Bzoma, B Samans, E Raschke, S Olek, ...Rheumatology 58 (11), 2015-2024, 2019201
12
2019
Cardiovascular outcomes in systemic sclerosis with abnormal cardiovascular MRI and serum cardiac biomarkers
RB Dumitru, LA Bissell, B Erhayiem, A Kidambi, AMH Dumitru, G Fent, ...RMD open 7 (3), e001689, 2021202
11
2021
Anti-carbamylated protein antibodies: are they useful for the diagnosis of rheumatoid arthritis
F Ponchel, MAM van Delft, X Xie, AN Burska, L Duquenne, LA Trouw, ...Clin Exp Rheumatol 39 (1), 146-150, 2021202
10
2021
Receptor activator of nuclear factor kappa-Β ligand (RANKL) serum levels are associated with progression to seropositive/negative rheumatoid arthritis
AN Burska, JJ El-Jawhari, J Wu, RJ Wakefield, H Marzo-Ortega, ...Clinical and Experimental Rheumatology 39 (3), 456-462, 2021202
8
2021
Intrinsic Type 1 Interferon (IFN1) Profile of Uncultured Human Bone Marrow CD45lowCD271+ Multipotential Stromal Cells (BM-MSCs): The Impact of Donor Age …
Intrinsic Type 1 Interferon (IFN1) Profile of Uncultured Human Bone Marrow CD45lowCD21+ Multipotential Stromal Cells (BM-MSCs): The Impact of Donor Age …P Ganguly, AN Burska, CLM Davis, JJ El-Jawhari, PV Giannoudis, ...Biomedicines 8 (), 214, 2020202
7
2020
Interferon-related gene expression in response to TNF inhibitor treatment in ankylosing spondylitis patients: a pilot study
SR Harrison, AN Burska, P Emery, H Marzo-Ortega, F PonchelRheumatology 60 (8), 3607-3616, 2021202
5
2021
Abnormal electrophysiological testing associates with future incidental significant arrhythmia in scleroderma
LA Bissell, RB Dumitru, B Erhayiem, G Abignano, G Fent, A Kidambi, ...Rheumatology 9 (4), 899-900, 2020202
5
2020
Type I interferon pathway assays in studies of rheumatic and musculoskeletal diseases: a systematic literature review informing EULAR points to consider
A Burska, J Rodríguez-Carrio, R Biesen, WA Dik, ML Eloranta, G Cavalli, ...RMD open 9 (1), e002876, 2023202
5
2023
Improvement in cardiovascular biomarkers sustained at 4 years following an initial treat-to-target strategy in early rheumatoid arthritis
Improvement in cardiovascular biomarkers sustained at years following an initial treat-to-target strategy in early rheumatoid arthritisI Mortimer, LA Bissell, EMA Hensor, L Kozera, SL Mackie, AN Burska, ...Rheumatology 58 (9), 168-1686, 2019201
4
2019
Association between type I interferon pathway activation and clinical outcomes in rheumatic and musculoskeletal diseases: a systematic literature review informing EULAR points …
J Rodríguez-Carrio, A Burska, PG Conaghan, WA Dik, R Biesen, ...RMD open 9 (1), e00286, 2023202
4
2023
Gene Expression and Autoantibody Analysis Revealing Distinct Ancestry‐Specific Profiles Associated With Response to Rituximab in Refractory Systemic Lupus Erythematosus
LM Carter, A Alase, Z Wigston, A Psarras, A Burska, E Sutton, MYM Yusof, ...Arthritis & Rheumatology 75 (5), 697-710, 20220
3
2023
Carotid artery volumetric measures associate with clinical ten-year cardiovascular (CV) risk scores and individual traditional CV risk factors in rheumatoid arthritis; a …
LA Bissell, B Erhayiem, G Fent, EMA Hensor, A Burska, H Donica, S Plein, ...Arthritis Research & Therapy 20, 1-11, 2018201
3
2018

Referred From: https://scholar.google.com/citations?user=6FR0KsgAAAAJ

Cited by
Citations 1612
h-index 19
i10-index 29
Recommended Journals
Open Access Journals